secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akebia Therapeutics, Inc. (AKBA)
CIK:        0001517022
Form:       8-K
Filed at:   2023-04-28T23:59:59+00:00
Accession:  0001193125-23-124259
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akebia amends bylaws to update proxy rules, stockholder meeting procedures
--------------------------------------------------------------------------

- Eliminates requirement to provide stockholder list during actual meeting.
- Addresses adjournment of meetings due to technical failure in remote communication.
- Enhances disclosure requirements for stockholder nominations under universal proxy rules.
- Imposes compliance deadlines and consequences for non-compliance with Rule 14a-19.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517022/000119312523124259/0001193125-23-124259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517022/000119312523124259/d455889d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-124259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer